New York, NY-- Paul Hastings LLP, a leading global law firm, represented UBS AG, Stamford Branch, J.P. Morgan Securities LLC, Jefferies Finance LLC, Keybank National Association, Morgan Stanley Senior Funding, Inc., Sumitomo Mitsui Banking Corp. and Barclays Bank PLC as joint lead arrangers and joint bookrunners on the financing in connection with the acquisition of a majority stake in vitamin-maker Royal DSM NV’s pharmaceuticals business by JLL Partners (“JLL”) through Patheon Inc., a Canada-based specialty-pharmaceuticals manufacturer controlled by JLL.
The financing consisted of a $985 million and €250 million term loan facility and a $200 million revolving facility.
Leveraged Finance partners Michael Michetti and Joel Simon led the Paul Hastings team, which also included associates Chris Ross, Heidi Spalholz, Sun Kim, Mitchell Zuckerman and Yian Huang.
Paul Hastings’ Leverage Finance practice has also recently advised the lenders on the acquisition financings of Southwire Company’s acquisition of Coleman Cable, Inc., Chuck E. Cheese’s operator by Apollo Global Management and Hellman & Friedman LLC’s purchase of Applied Systems Inc.
Paul Hastings LLP is a leading global law firm with offices in Asia, Europe, and the United States. We provide innovative legal solutions to financial institutions and Fortune 500 companies. Please visit www.paulhastings.com for more information.